Porton Announces Third Quarter 2021 Results
…
J-STAR Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on October 17-20. Our synergistically integrated DS-DP team will discuss the enabling technologies and unique capabilities at J-STAR for debottlenecking drug substance (DS) and drug product …
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph.D.), CTO of Porton/J-STAR Research, will be Keynote Speaker and CMC Speaker, respectively, at this year’s Sino-American Professionals Association (SAPA) Annual Conference on …
Chongqing, China,August 18, 2021-Porton Pharma Solutions Ltd. (Porton) today announced that it is to acquire 70% of equity of Hubei Yuyang Pharmaceutical Co., Ltd. (Yuyang) with the dealing price of RMB 171.5 million. The acquisition will enhance Porton’s existing capabilities …
Visit J-STAR Research and Porton at Booth 2243 from August 10th to 12th at this month’s CPhINorthAmerica event.
Our team will be available to discuss your drug development needs.
Schedule your meeting in advance: https://calendly.com/jstar-research/30min
Please click here for more …
The Center for Pharma Crystallization (CfPC) at J-STAR Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, …
The Center for Pharma Crystallization (CfPC) at J-STAR Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, …
On Saturday, June 6, Porton and Tianjin University National Engineering Research Center of Industrial Crystallization Technology (CICT) announced a school-enterprise strategic cooperation to jointly advance CICT’s resource investment, technology development, talent training, teaching, research, industry-university cooperation, and innovation.
The first …
May 25, 2002, Shanghai, China. Porton Pharma Solutions Ltd., one of the world’s leading CDMOs, today celebrated the groundbreaking of its new drug product GMP site. Construction of the facility began this month and will continue in phases until the …